Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Borgmann, Hendrik; Hofner, Thomas; Sasca, Daniel et al.

Pandemic Spread of COVID-19 Mutant Variants Will Facilitate Next-generation Sequencing Capacities for Personalised Medicine in Urologic Oncology

EUROPEAN UROLOGY. Bd. 79. H. 6. 2021 S. 895-896


Schmidt, M

Pathologie, Prognose und Prädiktion

Untch / Harbeck / Thomssen (Hrsg). Colloquium Senologie 2021 / 2022. München: Agileum 2021



Krajnak, Slavomir; Decker, Thomas; Schollenberger, Lukas et al.

Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2-breast cancer resistant to endocrine therapy: VinoMetro-AGO-B-046

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 147. H. 11. 2021 S. 3391-3400



Moebus, Volker; Lueck, Hans-Joachim; Ladda, Ekkehart et al.

Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2)

EUROPEAN JOURNAL OF CANCER. Bd. 156. 2021 S. 138-148


Liebers, Nora; Duell, Johannes; Fitzgerald, Donnacha et al.

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

BLOOD ADVANCES. Bd. 5. H. 13. 2021 S. 2707-2716


Gairing, Simon Johannes; Galle, Peter Robert; Schattenberg, Joern M. et al.

Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders

JOURNAL OF CLINICAL MEDICINE. Bd. 10. H. 23. 2021


Van der Kooi, Anne-Lotte L. F.; van Dijk, Marloes; Broer, Linda et al.

Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function

HUMAN REPRODUCTION. Bd. 36. H. 4. 2021 S. 1120-1133